Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2024Clinical Chemistry

B-146 Unlocking the potential of large-cohort proteomics studies with the Orbitrap Astral mass platform

View Full Paper
Ask AI
Bookmark
Share

Authors

XYXuan YuAPAnna PashkovaMZMark Zeller

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yu et al. (2024) studied this question.

synapsesocial.com/papers/68e5611fe2b3180350efe0ffhttps://doi.org/10.1093/clinchem/hvae106.506
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An inflection point in high-throughput proteomics with Orbitrap Astral: analysis of biofluids, cells, and tissues2024 · 6 citations
  2. 2Higher-Throughput Proteome Profiling Enabled by Parallelized Pre-Accumulation and Optimized Ion Processing in the Orbitrap Astral Zoom Mass Spectrometer2025
  3. 3An Inflection Point in High-Throughput Proteomics with Orbitrap Astral: Analysis of Biofluids, Cells, and Tissues2024 · 14 citations
  4. 4Technical Assessment on Proteonano™: A Robust Platform for Deep Plasma Proteomics Study2024
  5. 5Narrow window data-independent acquisition on the Orbitrap Astral Mass Spectrometer enables fast and deep coverage of the plasma glycoproteome2024 · 2 citations